Michael G. Kurilla

6.4k total citations · 1 hit paper
50 papers, 4.6k citations indexed

About

Michael G. Kurilla is a scholar working on Oncology, Immunology and Epidemiology. According to data from OpenAlex, Michael G. Kurilla has authored 50 papers receiving a total of 4.6k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Oncology, 22 papers in Immunology and 19 papers in Epidemiology. Recurrent topics in Michael G. Kurilla's work include Viral-associated cancers and disorders (27 papers), Immune Cell Function and Interaction (16 papers) and Lymphoma Diagnosis and Treatment (14 papers). Michael G. Kurilla is often cited by papers focused on Viral-associated cancers and disorders (27 papers), Immune Cell Function and Interaction (16 papers) and Lymphoma Diagnosis and Treatment (14 papers). Michael G. Kurilla collaborates with scholars based in United States, United Kingdom and Australia. Michael G. Kurilla's co-authors include Alan B. Rickinson, Jack D. Keene, E Kieff, Maria G. Masucci, R J Murray, Elliott Kieff, Martin Rowe, Wendy A. Thomas, George Klein and Denis J. Moss and has published in prestigious journals such as Nature, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Michael G. Kurilla

49 papers receiving 4.5k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Inhibition of antigen processing by the internal repeat region of the Epstein–Barr virus nuclear antigen-1

1995 634 citations Jelena Levitskaya, Victor Levitsky et al. Nature profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michael G. Kurilla United States	33	2.7k	2.3k	1.6k	1.1k	729	50	4.6k
Tatsuya Tsurumi Japan	42	2.5k 0.9×	1.1k 0.5×	2.5k 1.5×	530 0.5×	1.5k 2.0×	123	4.8k
Benjamin E. Gewurz United States	37	1.5k 0.5×	1.5k 0.7×	1.2k 0.7×	623 0.6×	1.2k 1.6×	81	3.9k
Kanji Hirai Japan	35	1.4k 0.5×	737 0.3×	2.0k 1.2×	603 0.6×	581 0.8×	147	3.7k
Maaike E. Ressing Netherlands	37	1.7k 0.6×	2.7k 1.2×	2.1k 1.3×	358 0.3×	1.0k 1.4×	73	4.4k
John Nicholas United States	33	3.2k 1.2×	736 0.3×	3.1k 1.9×	501 0.5×	497 0.7×	75	4.4k
Yorio Hinuma Japan	43	1.8k 0.7×	9.9k 4.3×	1.2k 0.7×	565 0.5×	927 1.3×	238	12.5k
Shannon C. Kenney United States	56	6.6k 2.4×	2.3k 1.0×	3.1k 1.9×	2.2k 2.0×	1.6k 2.1×	145	8.5k
U.K. Freese Germany	15	1.5k 0.5×	472 0.2×	1.5k 0.9×	528 0.5×	576 0.8×	17	2.7k
Jos Even France	32	1.3k 0.5×	3.2k 1.4×	518 0.3×	201 0.2×	903 1.2×	73	4.5k
Victor Levitsky Sweden	17	1.2k 0.4×	890 0.4×	625 0.4×	377 0.3×	312 0.4×	41	1.9k

Countries citing papers authored by Michael G. Kurilla

Since Specialization

Citations

This map shows the geographic impact of Michael G. Kurilla's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael G. Kurilla with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael G. Kurilla more than expected).

Fields of papers citing papers by Michael G. Kurilla

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael G. Kurilla. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael G. Kurilla. The network helps show where Michael G. Kurilla may publish in the future.

Co-authorship network of co-authors of Michael G. Kurilla

This figure shows the co-authorship network connecting the top 25 collaborators of Michael G. Kurilla. A scholar is included among the top collaborators of Michael G. Kurilla based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael G. Kurilla. Michael G. Kurilla is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Outterson, Kevin, John Rex, Peter Jackson, et al.. (2016). Accelerating global innovation to address antibacterial resistance: introducing CARB-X. Nature Reviews Drug Discovery. 15(9). 589–590. 43 indexed citations

Barbosa, Maria D.F.S., et al.. (2002). Development of a Whole-Cell Assay for Peptidoglycan Biosynthesis Inhibitors. Antimicrobial Agents and Chemotherapy. 46(4). 943–946. 43 indexed citations

Barbosa, Maria D.F.S., et al.. (2002). A Multitarget Assay for Inhibitors of Membrane-Associated Steps of Peptidoglycan Biosynthesis. Analytical Biochemistry. 306(1). 17–22. 18 indexed citations

Zhang, Yi, Fude Yang, Yeh‐Chih Kao, et al.. (2002). Homogenous Assays for Escherichia coli DnaB-Stimulated DnaG Primase and DnaB Helicase and Their Use in Screening for Chemical Inhibitors. Analytical Biochemistry. 304(2). 174–179. 22 indexed citations

Hobbs, Frank W., et al.. (2001). Oxazolidinones Mechanism of Action: Inhibition of the First Peptide Bond Formation. Journal of Biological Chemistry. 276(40). 37199–37205. 33 indexed citations

Feldman, Patricia, et al.. (2001). A Scintillation Proximity Assay for RNA Detection. Analytical Biochemistry. 289(2). 239–245. 14 indexed citations

Jin, Xia, Marie‐Ange Demoitié, Sean M. Donahoe, et al.. (2000). High Frequency of Cytomegalovirus‐Specific Cytotoxic T‐Effector Cells in HLA‐A*0201–Positive Subjects during Multiple Viral Coinfections. The Journal of Infectious Diseases. 181(1). 165–175. 58 indexed citations

Subklewe, Marion, Ann Chahroudi, Alan Schmaljohn, et al.. (1999). Induction of Epstein-Barr Virus-Specific Cytotoxic T-Lymphocyte Responses Using Dendritic Cells Pulsed With EBNA-3A Peptides or UV-Inactivated, Recombinant EBNA-3A Vaccinia Virus. Blood. 94(4). 1372–1381. 22 indexed citations

Subklewe, Marion, Ann Chahroudi, Kara Bickham, et al.. (1999). Presentation of Epstein-Barr virus latency antigens to CD8+, interferon-γ-secreting, T lymphocytes. European Journal of Immunology. 29(12). 3995–4001. 41 indexed citations

10.

Blake, Neil, Irina Redchenko, Wendy Thomas, et al.. (1997). Human CD8 + T Cell Responses to EBV EBNA1: HLA Class I Presentation of the (Gly-Ala)–Containing Protein Requires Exogenous Processing. Immunity. 7(6). 791–802. 222 indexed citations

11.

Shi, Yan, Kelly D. Smith, Michael G. Kurilla, & Charles T. Lutz. (1997). Cytotoxic CD8+ T cells recognize EBV antigen but poorly kill autologous EBV-infected B lymphoblasts: immunodominance is elicited by a peptide epitope that is presented at low levels in vitro. The Journal of Immunology. 159(4). 1844–1852. 25 indexed citations

12.

White, Catherine A., Simone Cross, Michael G. Kurilla, et al.. (1996). Recruitment during Infectious Mononucleosis of CD3+CD4+CD8+Virus-Specific Cytotoxic T Cells Which Recognise Epstein–Barr Virus Lytic Antigen BHRF1. Virology. 219(2). 489–492. 32 indexed citations

13.

Frisan, Teresa, et al.. (1996). Defective presentation of MHC class I-restricted cytotoxic T-cell epitopes in Burkitt's lymphoma cells. International Journal of Cancer. 68(2). 251–258. 35 indexed citations

14.

Levitskaya, Jelena, Victor Levitsky, Stefan Imreh, et al.. (1995). Inhibition of antigen processing by the internal repeat region of the Epstein–Barr virus nuclear antigen-1. Nature. 375(6533). 685–688. 634 indexed citations breakdown →

15.

Kurilla, Michael G., Thomas C. Heineman, L. Davenport, Elliott Kieff, & Lindsey Hutt‐Fletcher. (1995). A Novel Epstein-Barr Virus Glycoprotein gp150 Expressed from the BDLF3 Open Reading Frame. Virology. 209(1). 108–121. 20 indexed citations

16.

Khanna, Rajiv, et al.. (1995). Isolation of Cytotoxic T Lymphocytes from Healthy Seropositive Individuals Specific for Peptide Epitopes from Epstein–Barr Virus Nuclear Antigen 1: Implications for Viral Persistence and Tumor Surveillance1. Virology. 214(2). 633–637. 70 indexed citations

17.

Kurilla, Michael G.. (1993). Target antigens of Epstein-Barr virus (EBV) and the implications for immune control of EBV-associated disease. Seminars in Virology. 4(2). 95–100. 3 indexed citations

18.

Murray, R J, Michael G. Kurilla, Jill Brooks, et al.. (1992). Identification of target antigens for the human cytotoxic T cell response to Epstein-Barr virus (EBV): implications for the immune control of EBV-positive malignancies.. The Journal of Experimental Medicine. 176(1). 157–168. 428 indexed citations

19.

Khanna, Rajiv, Scott R. Burrows, Michael G. Kurilla, et al.. (1992). Localization of Epstein-Barr virus cytotoxic T cell epitopes using recombinant vaccinia: implications for vaccine development.. The Journal of Experimental Medicine. 176(1). 169–176. 337 indexed citations

20.

Fresco, Lucille D., Michael G. Kurilla, & Jack D. Keene. (1987). Rapid Inhibition of Processing and Assembly of Small Nuclear Ribonucleoproteins after Infection with Vesicular Stomatitis Virus. Molecular and Cellular Biology. 7(3). 1148–1155. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact